Somaxon Pharmaceuticals Inc (NASDAQ:SOMX.DL)

CAPS Rating: No stars

A pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.

Recs

2
Player Avatar SultanOfSwing (97.82) Submitted: 8/25/2010 11:51:33 AM : Outperform Start Price: $40.24 SOMX.DL Score: -139.32

Marketing deal with P&G for Silenor is a big, big deal.

Featured Broker Partners


Advertisement